Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Arcus Biosciences
< Previous
1
2
3
4
Next >
New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer
February 15, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
February 11, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium
February 10, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
January 24, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer
January 21, 2025
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
December 24, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
December 10, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
December 03, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
November 19, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
November 12, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update
November 06, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10, a Randomized Study in Patients with PD-L1-High Non-Small Cell Lung Cancer
November 05, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Present New Data for Anti-TIGIT Domvanalimab Plus Zimberelimab at the Society for Immunotherapy of Cancer Annual Meeting
October 30, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
October 24, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
First Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor, Casdatifan, Showed Promising Clinical Activity and Tumor Shrinkage in Patients with Metastatic Kidney Cancer
October 24, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Host Conference Call to Discuss Third-Quarter 2024 Financial Results and Pipeline Update
October 22, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
October 09, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium
October 09, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma
October 02, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
September 24, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
September 10, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital
August 27, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
August 26, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
August 21, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update
August 08, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update
July 25, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
July 09, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia
July 08, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
Arcus Biosciences Announces New Employment Inducement Grants
June 25, 2024
From
Arcus Biosciences
Via
Business Wire
Tickers
RCUS
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.